297 related articles for article (PubMed ID: 26319027)
1. A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements.
Jarosova M; Kriegova E; Schneiderova P; Fillerova R; Prochazka V; Mikesova M; Flodr P; Indrak K; Papajik T
Pathol Oncol Res; 2016 Apr; 22(2):233-43. PubMed ID: 26319027
[TBL] [Abstract][Full Text] [Related]
2. Non-immunoglobulin/BCL6 gene fusion in diffuse large B-cell lymphoma: prognostic implications.
Ueda C; Akasaka T; Ohno H
Leuk Lymphoma; 2002 Jul; 43(7):1375-81. PubMed ID: 12389616
[TBL] [Abstract][Full Text] [Related]
3. Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas.
Otto C; Scholtysik R; Schmitz R; Kreuz M; Becher C; Hummel M; Rosenwald A; Trümper L; Klapper W; Siebert R; Küppers R;
Genes Chromosomes Cancer; 2016 Dec; 55(12):932-943. PubMed ID: 27356265
[TBL] [Abstract][Full Text] [Related]
4. Nonimmunoglobulin (non-Ig)/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6.
Akasaka T; Ueda C; Kurata M; Akasaka H; Yamabe H; Uchiyama T; Ohno H
Blood; 2000 Oct; 96(8):2907-9. PubMed ID: 11023530
[TBL] [Abstract][Full Text] [Related]
5. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic and clinical implications of non-immunoglobulin ; BCL6 translocations in B-cell non-Hodgkin's lymphoma.
Ohno H
J Clin Exp Hematop; 2006 Nov; 46(2):43-53. PubMed ID: 17142954
[TBL] [Abstract][Full Text] [Related]
7. Intrachromosomal rearrangement of chromosome 3q27: an under recognized mechanism of BCL6 translocation in B-cell non-Hodgkin lymphoma.
Keller CE; Nandula S; Vakiani E; Alobeid B; Murty VV; Bhagat G
Hum Pathol; 2006 Aug; 37(8):1093-9. PubMed ID: 16867873
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH
Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
Akyurek N; Uner A; Benekli M; Barista I
Cancer; 2012 Sep; 118(17):4173-83. PubMed ID: 22213394
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma.
Wlodarska I; Stul M; De Wolf-Peeters C; Hagemeijer A
Haematologica; 2004 Aug; 89(8):965-72. PubMed ID: 15339680
[TBL] [Abstract][Full Text] [Related]
11. The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma.
Nakamura Y; Takahashi N; Kakegawa E; Yoshida K; Ito Y; Kayano H; Niitsu N; Jinnai I; Bessho M
Cancer Genet Cytogenet; 2008 Apr; 182(2):144-9. PubMed ID: 18406879
[TBL] [Abstract][Full Text] [Related]
12. Delineating the mechanism of fragility at BCL6 breakpoint region associated with translocations in diffuse large B cell lymphoma.
Gopalakrishnan V; Roy U; Srivastava S; Kariya KM; Sharma S; Javedakar SM; Choudhary B; Raghavan SC
Cell Mol Life Sci; 2024 Jan; 81(1):21. PubMed ID: 38196006
[TBL] [Abstract][Full Text] [Related]
13.
Tourneret A; Alame M; Rigau V; Bauchet L; Fabbro M; De Oliveira L; Cacheux V; Costes V; Lacheretz-Szablewski V
J Clin Pathol; 2021 Oct; 74(10):650-656. PubMed ID: 32912960
[TBL] [Abstract][Full Text] [Related]
14. Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.
Yonetani N; Akasaka T; Akasaka H; Ohno H; Okuma M; Miura I; Takahashi N; Miyanishi S; Okumura A; Muramatsu M; Fukuhara S
Oncogene; 1998 Aug; 17(8):971-9. PubMed ID: 9747876
[TBL] [Abstract][Full Text] [Related]
15. High-resolution architecture and partner genes of
Chong LC; Ben-Neriah S; Slack GW; Freeman C; Ennishi D; Mottok A; Collinge B; Abrisqueta P; Farinha P; Boyle M; Meissner B; Kridel R; Gerrie AS; Villa D; Savage KJ; Sehn LH; Siebert R; Morin RD; Gascoyne RD; Marra MA; Connors JM; Mungall AJ; Steidl C; Scott DW
Blood Adv; 2018 Oct; 2(20):2755-2765. PubMed ID: 30348671
[TBL] [Abstract][Full Text] [Related]
16. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of BCL6 translocation partner genes in primary gastric high-grade B-cell lymphoma: heat shock protein 89 alpha is a novel fusion partner gene of BCL6.
Xu WS; Liang RH; Srivastava G
Genes Chromosomes Cancer; 2000 Jan; 27(1):69-75. PubMed ID: 10564588
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
Niitsu N; Okamoto M; Nakamura N; Nakamine H; Aoki S; Hirano M; Miura I
Leuk Res; 2007 Sep; 31(9):1191-7. PubMed ID: 17197022
[TBL] [Abstract][Full Text] [Related]
19. t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.
Gu K; Fu K; Jain S; Liu Z; Iqbal J; Li M; Sanger WG; Weisenburger DD; Greiner TC; Aoun P; Dave BJ; Chan WC
Mod Pathol; 2009 Sep; 22(9):1251-7. PubMed ID: 19465899
[TBL] [Abstract][Full Text] [Related]
20. MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma.
Kawamoto K; Miyoshi H; Yoshida N; Nakamura N; Ohshima K; Sone H; Takizawa J
Cancer Sci; 2016 Jun; 107(6):853-61. PubMed ID: 27027803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
